Optimising stereotactic body radiotherapy for non-small cell lung cancer with volumetric intensity-modulated arc therapy-a planning study

Clinical Oncology

Volumn 24, Issue 1, 2012, Pages 68-75

  Brock, J ^a   Bedford, J ^a   Partridge, M ^a   McDonald, F ^a   Ashley, S ^a   McNair, H A ^a   Brada, M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Arc; Hypofractionation; Lung; Radiotherapy; Tolerance

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; RADIATION DOSE; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT PLANNING; VOLUMETRIC INTENSITY MODULATED ARC THERAPY;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; RADIATION DOSAGE; RADIOSURGERY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84455181494     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2011.02.003     Document Type: Article

References (50)

1. Qiao X., Tullgren O., Lax I., Sirzen F., Lewensohn R. The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 2003, 41(1):1-11.
2. Martin A., Gaya A. Stereotactic body radiotherapy: a review. Clin Oncol (R Coll Radiol) 2010, 22(3):157-172.
3. Baumann P., Nyman J., Lax I., et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol 2006, 45(7):787-795.
4. Beitler J.J., Badine E.A., El-Sayah D., et al. Stereotactic body radiation therapy for nonmetastatic lung cancer: an analysis of 75 patients treated over 5 years. Int J Radiat Oncol Biol Phys 2006, 65(1):100-106.
5. Faria S.L., Souhami L., Portelance L., et al. Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer. Radiat Oncol 2006, 1:42.
6. Fukumoto S., Shirato H., Shimzu S., et al. Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable stage I nonsmall cell lung carcinomas. Cancer 2002, 95(7):1546-1553.
7. Lee S.W., Choi E.K., Park H.J., et al. Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lung Cancer 2003, 40(3):309-315.
8. Nagata Y., Takayama K., Matsuo Y., et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005, 63(5):1427-1431.
9. Ng A.W., Tung S.Y., Wong V.Y. Hypofractionated stereotactic radiotherapy for medically inoperable stage I non-small cell lung cancer - report on clinical outcome and dose to critical organs. Radiother Oncol 2008, 87(1):24-28.
10. Onimaru R., Shirato H., Shimizu S., et al. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 2003, 56(1):126-135.
11. Onishi H., Araki T., Shirato H., et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004, 101(7):1623-1631.
12. Uematsu M., Shioda A., Suda A., et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys 2001, 51(3):666-670.
13. Xia T., Li H., Sun Q., et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006, 66(1):117-125.
14. Brock J., Ashley S., Bedford J., Nioutsikou E., Partridge M., Brada M. Review of hypofractionated small volume radiotherapy for early-stage non-small cell lung cancer. Clin Oncol (R Coll Radiol) 2008, 20(9):666-676.
15. Nyman J., Johansson K.A., Hulten U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer - mature results for medically inoperable patients. Lung Cancer 2006, 51(1):97-103.
16. Uematsu M., Shioda A., Tahara K., et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer 1998, 82(6):1062-1070.
17. Purdie T.G., Bissonnette J.P., Franks K., et al. Cone-beam computed tomography for on-line image guidance of lung stereotactic radiotherapy: localization, verification, and intrafraction tumor position. Int J Radiat Oncol Biol Phys 2007, 68(1):243-252.
18. Bedford J.L., Nordmark Hansen V., McNair H.A., et al. Treatment of lung cancer using volumetric modulated arc therapy and image guidance: a case study. Acta Oncol 2008, 47(7):1438-1443.
19. McNair H.A., Brock J., Symonds-Tayler J.R., et al. Feasibility of the use of the Active Breathing Coordinator (ABC) in patients receiving radical radiotherapy for non-small cell lung cancer (NSCLC). Radiother Oncol 2009, 93(3):424-429.
20. Panakis N., McNair H.A., Christian J.A., et al. Defining the margins in the radical radiotherapy of non-small cell lung cancer (NSCLC) with active breathing control (ABC) and the effect on physical lung parameters. Radiother Oncol 2008, 87(1):65-73.
21. Bedford J.L., Brock J., McNair H.M., Brada M., Warrington A. Evaluation of intensity-modulated arc therapy for radical radiotherapy of non-small cell lung cancer. Radiother Oncol 2007, 84:S208-S209.
22. Bedford J.L., Webb S. Elimination of importance factors for clinically accurate selection of beam orientations, beam weights and wedge angles in conformal radiation therapy. Med Phys 2003, 30(7):1788-1804.
23. Bedford J.L. Treatment planning for volumetric modulated arc therapy. Med Phys 2009, 36(11):5128-5138.
24. Claude L., Perol D., Ginestet C., et al. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis. Radiother Oncol 2004, 71(2):175-181.
25. Graham M.V., Purdy J.A., Emami B., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999, 45(2):323-329.
26. Tsujino K., Hirota S., Endo M., et al. Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 2003, 55(1):110-115.
27. Clenton S.J., Fisher P.M., Conway J., Kirkbride P., Hatton M.Q. The use of lung dose-volume histograms in predicting post-radiation pneumonitis after non-conventionally fractionated radiotherapy for thoracic carcinoma. Clin Oncol (R Coll Radiol) 2005, 17(8):599-603.
28. Franks K.N., Bezjak A., Purdie T.G., et al. Early results of image-guided radiation therapy in lung stereotactic body radiotherapy (SBRT). Clin Oncol (R Coll Radiol) 2007, 19(3):S10.
29. Bradley J., Deasy J.O., Bentzen S., El-Naqa I. Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma. Int J Radiat Oncol Biol Phys 2004, 58(4):1106-1113.
30. Ahn S.J., Kahn D., Zhou S., et al. Dosimetric and clinical predictors for radiation-induced esophageal injury. Int J Radiat Oncol Biol Phys 2005, 61(2):335-347.
31. Akagi Y., Hirokawa Y., Kagemoto M., et al. Optimum fractionation for high-dose-rate endoesophageal brachytherapy following external irradiation of early stage esophageal cancer. Int J Radiat Oncol Biol Phys 1999, 43(3):525-530.
32. Arvidson N.B., Mehta M.P., Tome W.A. Dose coverage beyond the gross tumor volume for various stereotactic body radiotherapy planning techniques reporting similar control rates for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008, 72(5):1597-1603.
33. International Commission on Radiation Units and Measurement Prescribing, recording and reporting photon beam therapy. ICRU Report 50 1993, International Commission on Radiation Units and Measurements, Bethesda, MD.
34. International Commission on Radiation Units and Measurement ICRU Report 62: prescribing, recording and reporting photon beam therapy (Supplement to ICRU Report 50) 1999, International Commission on Radiation Units and Measurement, Bethesda, MD.
35. Lax I., Blomgren H., Naslund I., Svanstrom R. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 1994, 33(6):677-683.
36. de Pooter J.A., Mendez Romero A., Jansen W.P., et al. Computer optimization of noncoplanar beam setups improves stereotactic treatment of liver tumors. Int J Radiat Oncol Biol Phys 2006, 66(3):913-922.
37. Liu R., Buatti J.M., Howes T.L., Dill J., Modrick J.M., Meeks S.L. Optimal number of beams for stereotactic body radiotherapy of lung and liver lesions. Int J Radiat Oncol Biol Phys 2006, 66(3):906-912.
38. McGrath S.D., Matuszak M.M., Yan D., Kestin L.L., Martinez A.A., Grills I.S. Volumetric modulated arc therapy for delivery of hypofractionated stereotactic lung radiotherapy: a dosimetric and treatment efficiency analysis. Radiother Oncol 2010, 95(2):153-157.
39. Bedford J.L., Warrington A.P. Commissioning of volumetric modulated arc therapy (VMAT). Int J Radiat Oncol Biol Phys 2009, 73(2):537-545.
40. Hoppe B.S., Laser B., Kowalski A.V., et al. Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who's at risk?. Int J Radiat Oncol Biol Phys 2008, 72(5):1283-1286.
41. Verbakel W.F., Senan S., Cuijpers J.P., Slotman B.J., Lagerwaard F.J. Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensity-modulated arcs. Radiother Oncol 2009, 93(1):122-124.
42. Hall E.J., Wuu C.S. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003, 56(1):83-88.
43. Kry S.F., Salehpour M., Followill D.S., et al. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2005, 62(4):1195-1203.
44. Bral S., Van Parijs H., Soete G., et al. A feasibility study of image-guided hypofractionated conformal arc therapy for inoperable patients with localized non-small cell lung cancer. Radiother Oncol 2007, 84(3):252-256.
45. Onishi H., Kuriyama K., Komiyama T., et al. Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner. Lung Cancer 2004, 45(1):45-55.
46. Lagerwaard F.J., Haasbeek C.J., Smit E.F., Slotman B.J., Senan S. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008, 70(3):685-692.
47. Zimmermann F.B., Geinitz H., Schill S., et al. Stereotactic hypofractionatedradiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC). Acta Oncol 2006, 45(7):796-801.
48. Franks K.N., Purdie T.G., Dawson L.A., Bezjak A., Jaffray D.A., Bissonnette J.P. Incorporating heterogeneity correction and 4DCT in lung stereotactic body radiation therapy (SBRT): the effect on target coverage, organ-at-risk doses, and dose conformity. Med Dosim 2010, 35(2):101-107.
49. Underberg R.W., Lagerwaard F.J., Cuijpers J.P., Slotman B.J., van Sornsen de Koste J.R., Senan S. Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer. Int J Radiat Oncol Biol Phys 2004, 60(4):1283-1290.
50. Underberg R.W., Lagerwaard F.J., Slotman B.J., Cuijpers J.P., Senan S. Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: an analysis of 4DCT datasets. Int J Radiat Oncol Biol Phys 2005, 62(2):554-560.